Trial Profile
Anlotinib Hydrochloride Capsules in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Open, Single Arm, Exploratory Clinical Trial
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2021
Price :
$35
*
At a glance
- Drugs Catequentinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms ATAHC
- 13 Dec 2018 New trial record